David Porter of the Perelman School of Medicine discusses working with Novartis on a new way to treat leukemia.
Perelman School of Medicine
Jason Karlawish of the Perelman School of Medicine is quoted about questions that arise about the stigma that accompanies Alzheimer’s testing.
Baligh Yehia of the Perelman School of Medicine comments on studying hepatitis C treatment in the U.S.
Carl June of the Perelman School of Medicine is quoted about research on experimental leukemia therapy.
A team of scientists and physicians at the University of Pennsylvania will lead a four-year effort worth as much as $22.5 million to develop next-generation technologies to restore memory function in people who suffer from memory loss due to disease or traumatic injury.
A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration’s Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).
Edna Foa of the Perelman School of Medicine is featured for developing a therapy that requires patients to relive a horrific event to lessen its power.
Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School predicts massive changes in the traditional role of health insurers by 2025.